Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
Clinical trial NCT03636893 · COMPLETED
Trial details
- NCT number
- NCT03636893
- Sponsor
- Ruijin Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2020-03-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.